UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients with Autoimmune Hepatitis

Clinical gastroenterology and hepatology, 2017-12, Vol.15 (12), p.1950-1956.e1

2017

Volltextzugriff (PDF)

Nutritional status and prognosis in cirrhotic patients

Alimentary pharmacology & therapeutics, 2006-08, Vol.24 (4), p.563-572

2006

Volltextzugriff (PDF)

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting

Journal of viral hepatitis, 2015-05, Vol.22 (5), p.504-510

2015

Volltextzugriff (PDF)

399 DELTA VIRUS COINFECTION DOES NOT INCREASE, BUT HCV COINFECTION INCREASE THE HBSAG LOSS, IN CHRONIC HBV INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S159-S160

2011

Volltextzugriff (PDF)

Safety, tolerability, and efficacy of pegylated‐interferon alfa‐2a plus ribavirin in HCV‐related decompensated cirrhotics

Alimentary pharmacology & therapeutics, 2008-06, Vol.27 (11), p.1081-1085

2008

Volltextzugriff (PDF)

P928 TELBIVUDIN: MORE CAUTION IS NEEDED IN LIVER TRANSPLANT RECIPIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S384-S384

2014

Volltextzugriff (PDF)

Late hepatic artery thrombosis after orthotopic liver transplantation

Liver transplantation, 2003-06, Vol.9 (6), p.605-611

2003

Volltextzugriff (PDF)

P1087 ENTECAVIR AND TENOFOVIR MONOTHERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER TURKISH STUDY IN CLINICAL PRACTICE

Journal of hepatology, 2014-04, Vol.60 (1), p.S440-S440

2014

Volltextzugriff (PDF)

492 IL28B GENOTYPE HAS NO IMPACT ON SPONTANEOUS HEPATITIS B SURFACE ANTIGEN (HBSAG) CLEARANCE IN INACTIVE CARRIERS: A LONG TERM, CASE-MATCHED RETROSPECTIVE COHORT STUDY

Journal of hepatology, 2012-04, Vol.56, p.S193-S193

2012

Volltextzugriff (PDF)

Long‐term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow‐up to 12 years

Alimentary pharmacology & therapeutics, 2005-02, Vol.21 (3), p.217-226

2005

Volltextzugriff (PDF)

Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach

Alimentary pharmacology & therapeutics, 2010-03, Vol.31 (5), p.573-582

2010

Volltextzugriff (PDF)

342 A PROSPECTIVE EVALUATION OF HISTOLOGIC CHANGES IN NON-ALCOHOLIC FATTY LIVER DISEASE

Journal of hepatology, 2010, Vol.52, p.S143-S143

2010

Volltextzugriff (PDF)

162 EFFECTS OF ERYTHROPOIETIN IN THIOACETAMIDE INDUCED FULMINANT HEPATIC FAILURE IN RATS

Journal of hepatology, 2009, Vol.50, p.S69-S69

2009

Volltextzugriff (PDF)

737 HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE RATES AND ASSOCIATED FACTORS IN CHRONIC HEPATITIS B INFECTION

Journal of hepatology, 2010, Vol.52, p.S287-S287

2010

Volltextzugriff (PDF)

Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity

Scandinavian journal of gastroenterology, 2004-10, Vol.39 (10), p.981-987

2004

Volltextzugriff (PDF)

997 FIBROSIS SHOULD BE INCLUDED INTO THE NON- ALCOHOLIC STEATOHEPATITIS SCORING SYSTEM FOR BEING MORE PROGNOSTICATIVE

Journal of hepatology, 2009, Vol.50, p.S361-S362

2009

Volltextzugriff (PDF)

A Pilot Study: Longer Duration of Posttransplant Hepatitis C Virus Therapy May Increase the Sustained Response Rate

Transplantation proceedings, 2009-11, Vol.41 (9), p.3806-3809

2009

Volltextzugriff (PDF)

HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence

Journal of viral hepatitis, 2005-03, Vol.12 (2), p.212-215

2005

Volltextzugriff (PDF)

Living Donor Liver Transplantation From Hepatitis B Core Antibody Positive Donors

Transplantation proceedings, 2007-06, Vol.39 (5), p.1488-1490

2007

Volltextzugriff (PDF)

Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract

Gastrointestinal endoscopy, 2003-02, Vol.57 (2), p.156-159

2003

Volltextzugriff (PDF)

Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation

Transplantation proceedings, 2004-06, Vol.36 (5), p.1442-1444

2004

Volltextzugriff (PDF)

674 CORRELATION OF IMMUNOHISTOCHEMISTRY ON LIVER BIOPSY AND SERUM HBVDNA LEVELS

Journal of hepatology, 2008, Vol.48, p.S251-S251

2008

Volltextzugriff (PDF)

Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis

The American journal of gastroenterology, 2019-07, Vol.114 (7), p.1101-1108

2019

Volltextzugriff (PDF)

[162] LAMIVUDINE MONOPROPHYLAXIS PREVENTS HBV INFECTION IN RECIPIENTS UNDERGOING LIVE DONOR LIVER TRANSPLANTATION BECAUSE OF NON-HBV RELATED DISEASES, HAVING THEIR GRAFTS FROM CORE-ANTIBODY POSITIVE DONORS

Journal of hepatology, 2007, Vol.46, p.S71-S71

2007

Volltextzugriff (PDF)

Biochemical, histological parameters and response to UDCA treatment in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

Journal of hepatology, 2001-04, Vol.34, p.216-217

Gunsar, F

2001

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(71)
Tagungsberichte
(1)

Sprache

Englisch
(70)
Türkisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Humans
(32)
Female
(28)
Male
(25)
Adult
(23)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Gastroenterology & Hepatology
(22)
Middle Aged
(22)
Aged
(18)
Treatment Outcome
(14)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Gastroenterology And Hepatology
(12)
Other Diseases. Semiology
(11)
Liver Transplantation
(10)
Digestive System Diseases
(8)
Infectious Diseases
(8)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(8)
Pharmacology. Drug Treatments
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients with Autoimmune Hepatitis

Nutritional status and prognosis in cirrhotic patients

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting

399 DELTA VIRUS COINFECTION DOES NOT INCREASE, BUT HCV COINFECTION INCREASE THE HBSAG LOSS, IN CHRONIC HBV INFECTION

Safety, tolerability, and efficacy of pegylated‐interferon alfa‐2a plus ribavirin in HCV‐related decompensated cirrhotics

P928 TELBIVUDIN: MORE CAUTION IS NEEDED IN LIVER TRANSPLANT RECIPIENTS

Late hepatic artery thrombosis after orthotopic liver transplantation

P1087 ENTECAVIR AND TENOFOVIR MONOTHERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER TURKISH STUDY IN CLINICAL PRACTICE

492 IL28B GENOTYPE HAS NO IMPACT ON SPONTANEOUS HEPATITIS B SURFACE ANTIGEN (HBSAG) CLEARANCE IN INACTIVE CARRIERS: A LONG TERM, CASE-MATCHED RETROSPECTIVE COHORT STUDY

Long‐term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow‐up to 12 years

Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach

342 A PROSPECTIVE EVALUATION OF HISTOLOGIC CHANGES IN NON-ALCOHOLIC FATTY LIVER DISEASE

162 EFFECTS OF ERYTHROPOIETIN IN THIOACETAMIDE INDUCED FULMINANT HEPATIC FAILURE IN RATS

737 HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE RATES AND ASSOCIATED FACTORS IN CHRONIC HEPATITIS B INFECTION

Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity

997 FIBROSIS SHOULD BE INCLUDED INTO THE NON- ALCOHOLIC STEATOHEPATITIS SCORING SYSTEM FOR BEING MORE PROGNOSTICATIVE

A Pilot Study: Longer Duration of Posttransplant Hepatitis C Virus Therapy May Increase the Sustained Response Rate

HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence

Living Donor Liver Transplantation From Hepatitis B Core Antibody Positive Donors

Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract

Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation

674 CORRELATION OF IMMUNOHISTOCHEMISTRY ON LIVER BIOPSY AND SERUM HBVDNA LEVELS

Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis

[162] LAMIVUDINE MONOPROPHYLAXIS PREVENTS HBV INFECTION IN RECIPIENTS UNDERGOING LIVE DONOR LIVER TRANSPLANTATION BECAUSE OF NON-HBV RELATED DISEASES, HAVING THEIR GRAFTS FROM CORE-ANTIBODY POSITIVE DONORS

Biochemical, histological parameters and response to UDCA treatment in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

Suchergebnisse filtern